The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA
COTA
Translates complex clinical data into real-world evidence to improve oncology patient care.
What they do
COTA curates and analyzes deep clinical data using its proprietary technology platform to assist oncologists, healthcare providers, and life science companies. By organizing unstructured medical records, the platform provides actionable insights and real-world evidence to optimize cancer treatment and research.
The record
- Vertical
- Oncology
- Sub-segment
- Real-world data and analytics
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Boston, United States
- Region
- North America
- Founded
- 2011
- Total funding
- $111M raised
Notable investors: Varian Medical Systems, MDSV, Horizon Blue Cross Blue Shield.
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
How Much Weight Does Real-World Evidence Actually Carry at FDA?
Dr. Dereck Mush, MD, MBA
The GLP-1 Data Nobody Puts in the Deck: Adherence, Regain and What Payers Now Model
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
She Lost 60 Pounds on Ozempic. Then Her Insurance Stopped Covering It.
She Lost 60 Pounds on Ozempic. Then Her Insurance Stopped Covering It.
Dr. Dereck Mush, MD, MBA